Hyperthermic intraperitoneal chemotherapy procedure for uterine sarcoma following a COVID-19 infection---case report

In the current context of the COVID-19 pandemic, major oncologic surgery sometimes had to be postponed for fear of overcrowding the intensive care units, the risk of cross-contamination or the risk of severe morbidity and mortality associated witha perioperative COVID-19 infection. In this setting, we want to present the first case of a patient who received a hyperthermic intraperitoneal chemotherapy (HIPEC) procedure for uterine sarcoma following a COVID-19 infection. To date, the patient is in good condition and has not developed any postoperative complications.

COVID-19; SARS-CoV-2; HIPEC

[1] Alradhawi M, Shubber N, Sheppard J, Ali Y. Effects of the COVID-19 pandemic on mental well-being amongst individuals in society- a letter to the editor on “the socio-economic implications of the coronavirus and COVID-19 pandemic: a review”. International Journal of Surgery. 2020; 78: 147–148.

[2] Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. International Journal of Surgery. 2020; 78: 185–193.

[3] Society of Surgical Oncology. Cancer surgeries in the time of COVID-19: a message from the SSO President and PresidentElect. 2020. Available at: https://www.surgonc.org/wp-con tent/uploads/2020/03/COVID-19-Letter-to-Members.pdf (Accessed: 20 August 2020).

[4] Surgeons ACo. Guidelines for triage and management of elective cancer surgery cases during the acute and recovery phases of coronavirus disease 2019 (COVID-19) pandemic. 2020.

[5] Classe JM, Dolivet G, Evrard S, Ferron G, Lécuru F, Leufflen L, et al. French Society for Surgical Oncology (SFCO) guidelines for the management of surgical oncology in the pandemic context of COVID 19. Bull Cancer. 2020; 107: 524–527.

[6] Torrance HDT, Longbottom ER, Vivian ME, Lalabekyan B, Abbott TEF, Ackland GL, et al. Post-operative immune suppression is mediated via reversible, Interleukin-10 dependent pathways in circulating monocytes following major abdominal surgery. PLoS ONE. 2018; 13: e0203795.

[7] Collaborative CO. Global guidance for surgical care during the COVID-19 pandemic. British Journal of Surgery. 2020; 107: 1097–1103.

[8] Brindle ME, Gawande A. Managing COVID-19 in surgical systems. Annals of Surgery. 2020; 272: e1–e2.

[9] Solanki S, Mukherjee S, Agarwal V, Thota R, Balakrishnan K, Shah S, et al. Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian Journal of Anaesthesia. 2019; 63: 972.

[10] Wolters Kluwer. UpToDate. 2020. Available at: www.uptodate.c om (Accessed: 10 September 2020).

[11] Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection - challenges and implications. New England Journal of Medicine. 2020; 383: e38.

[12] COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. The Lancet. 2020; 396: 27–38.